Angiogenin, bFGF and VEGF: Angiogenic markers in breath condensate of patients with pulmonary hypertension;Die angiogenetischen faktoren VEGF, angiogenin und bFGF im atemkondensat von patienten mit pulmonaler hypertonie

Pneumologie

Volumn 69, Issue 4, 2015, Pages 207-211

  Seyfarth, H J ^a   Sack, U ^a   Gessner, C ^a   Wirtz, H ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIN; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR 2; PANCREATIC RIBONUCLEASE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; BREATH CONDENSATE; BREATHING; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOASSAY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; BREATH ANALYSIS; COMPLICATION; FEMALE; HYPERTENSION, PULMONARY; MALE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

BIOMARKERS; BREATH TESTS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; REPRODUCIBILITY OF RESULTS; RIBONUCLEASE, PANCREATIC; SENSITIVITY AND SPECIFICITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84927131663     PISSN: 09348387     EISSN: 14388790     Source Type: Journal    
DOI: 10.1055/s-0034-1391775     Document Type: Article

References (16)

1. Simonneau G., Gatzoulis M. A., Adatia I. et al. Updated clinical classification of pulmonary hypertension. JACC: 2013; 62 D34 D41
2. Jonigk D., Golpon H., Bockmeyer C. L. et al. Plexiform lesions in pulmonary arterial hypertension - Composition, architecture, and microenvironment. AJP: 2011; 179 167 179
3. Moser K. M., Bloor C. M. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest: 1993; 103 686 692
4. Tuder R. M., Chacon M., Alger L. et al. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol: 2001; 195 367 374
5. Malhotra R., Paskin-Flerlage S., Zamanian R. T. et al. Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertension. Pulm Circ: 2013; 3 369 380
6. Gessner C., Hammerschmidt S., Kuhn H. et al. Expired diagnosis? - the potential of exhaled breath analysis. Pneumologie: 2014; 58 230 237
7. Gessner C., Rechner B., Hammerschmidt S. et al. Angiogenic markers in breath condensate identify non-small cell lung cancer. Lung cancer: 2010; 68 177 184
8. Sack U., Scheibe R., Wotzel M. et al. Multiplex analysis of cytokines in exhaled breath condensate. Cytometry A: 2006; 69 169 172
9. Gessner C., Scheibe R., Wotzel M. et al. Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease. Respir Med: 2005; 99 1229 1240
10. Huszar E., Vass G., Vizi E. et al. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur Respir J: 2002; 20 1393 1398
11. Elfros R. M., Hoagland K. W., Bosbous M. et al. Dilution of respiratory solutes in exhaled condensates. Am J Respir Crit Care Med: 2002; 165 663 669
12. Carratu P., Scoditti C., Maniscalco M. et al. Exhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertension. BMC Pulm Med: 2008; 8 20
13. Warwick G., Kotlyar E., Chow S. et al. Exhaled breath condensate in pulmonary arterial hypertension. J Breath Res: 2012; 6 036006
14. He H., Tao Y., Chen X. et al. High levels of interleukin-6 and 8-iso-prostaglandin in the exhaled breath condensate and serum of patients with chronic obstructive pulmonary disease related pulmonary hypertension. Chin Med J: 2014; 127 1608 1612
15. Quarck R., Nawrot T., Meyns B. et al. C-reactive protein: a new predictor of adverse outcome in pulmonary hypertension. J Am Coll Cardiol: 2009; 53 1211 1218
16. Papaioannou A., Zakynthinos E., Kostikas K. et al. Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis. BMC Pulm Med: 2009; 9 18